Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

We recently compiled a list of the Jim Cramer Recently Discussed These 17 Stocks And Chinese Hackers. In this article, we are ...

A patient advocacy group has started a campaign to stop Novo Nordisk from following through on a plan to stop making insulin product ... Tresiba made just over $1.1 billion last year, including ...

Nonprescription insulin is made from older formulations of diabetes ... Walmart teamed up with drugmaker Novo Nordisk to sell its own brand, called ReliOn insulin, which sells for as little ...

Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the ...

California aimed to disrupt pharmaceutical market When he announced the Civica deal in early 2023, Newsom made it ... brand-name insulin manufacturers — Eli Lilly, Novo Nordisk and Sanofi ...

Novo Nordisk has faced a massive selloff in recent months amid disappointing drug trials and U.S. pressure to cut its prices.

In terms of value market share, Novo Nordisk dominates 44.50% of the global insulin market share ... A similar argument can be made when considering the much more famous PE Ratio, in this case ...

As concerns around knockoffs of newer GLP-1 drugs like Ozempic and Wegovy take center stage, Novo Nordisk’s efforts ... weight loss drug Saxenda and its insulin-degludec-based diabetes ...

When he announced the Civica deal in early 2023, Newsom made it clear that the ... The three major brand-name insulin manufacturers — Eli Lilly, Novo Nordisk and Sanofi — cut prices between ...